In September 2024, the Australian Government published the final report of the Health Technology Assessment (HTA) Policy and Methods Review. On the surface, it is a national reform document. In …
Tag:
#HealthEconomics
-
-
Why access preparedness has become a strategic asset in 2026 Europe still enters many life-science strategy discussions as a question of timing rather than design. Launch later, once the US …
-
Early Value Assessments are not shortcuts to reimbursement. They are tests of whether a technology deserves the NHS’s attention while uncertainty is still unresolved. In recent years, NICE has been …
-
What Medicare’s DMHT Codes Signal for Digital Therapeutics Reimbursement and Why Healthcare Is Paying Attention Digital therapeutics reimbursement refers to how public and private healthcare systems pay for evidence-based software …
-
France 2030 medical device funding is a major public investment opportunity for teams developing implantable medical devices and next-generation surgical robotics. Managed via Bpifrance under the France 2030 investment plan, …
-
How Reimbursement Actually Works in Poland This paper explains how reimbursement in Poland actually works for MedTech, IVD, digital health, and AI technologies — including the role of NFZ, DRGs …
-
Belgium’s DRG debate is often framed as a shift toward “case-based payment.” That description is technically correct but strategically misleading. In Belgium, DRGs are not a market-shaping instrument; they are …
-
Germany rarely announces a reimbursement change with fanfare. It tends to arrive indirectly through regulation, measurement, and administrative architecture. Sepsis is the latest example. From 1 January 2026, sepsis care …
-
Why “SaMD” Is the Wrong Place to Start On paper, Software as a Medical Device (SaMD) looks like progress.It gives artificial intelligence in healthcare a name, a definition, and a …
-
What age-based CA125 thresholds reveal about winning adoption in NHS cancer pathways NICE Redefines Ovarian Cancer Testing More women with ovarian cancer in England could be diagnosed earlier and more …